268 related articles for article (PubMed ID: 31801289)
21. Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2.
Xu R; Garcia-Barros M; Wen S; Li F; Lin CL; Hannun YA; Obeid LM; Mao C
Cell Death Differ; 2018 May; 25(5):841-856. PubMed ID: 29229990
[TBL] [Abstract][Full Text] [Related]
22. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
23. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
24. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
25. Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046
[TBL] [Abstract][Full Text] [Related]
26. Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.
Coant N; Hannun YA
Adv Biol Regul; 2019 Jan; 71():141-146. PubMed ID: 30389354
[TBL] [Abstract][Full Text] [Related]
27. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
[TBL] [Abstract][Full Text] [Related]
28. Hydrolytic pathway protects against ceramide-induced apoptosis in keratinocytes exposed to UVB.
Uchida Y; Houben E; Park K; Douangpanya S; Lee YM; Wu BX; Hannun YA; Radin NS; Elias PM; Holleran WM
J Invest Dermatol; 2010 Oct; 130(10):2472-80. PubMed ID: 20520628
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
Momchilova A; Pankov R; Staneva G; Pankov S; Krastev P; Vassileva E; Hazarosova R; Krastev N; Robev B; Nikolova B; Pinkas A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142801
[TBL] [Abstract][Full Text] [Related]
30. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
31. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids.
Geoffroy K; Wiernsperger N; Lagarde M; El Bawab S
J Biol Chem; 2004 Aug; 279(33):34343-52. PubMed ID: 15184394
[TBL] [Abstract][Full Text] [Related]
32. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
Mao C; Obeid LM
Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
[TBL] [Abstract][Full Text] [Related]
33. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Sasaki H; Toyomura K; Matsuzaki W; Okamoto A; Yamaguchi N; Nakamura H; Murayama T
Arch Biochem Biophys; 2014 May; 550-551():12-9. PubMed ID: 24708996
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer.
Grbčić P; Sedić M
Molecules; 2020 May; 25(10):. PubMed ID: 32456134
[TBL] [Abstract][Full Text] [Related]
35. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
36. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.
Gault CR; Obeid LM
Crit Rev Biochem Mol Biol; 2011 Aug; 46(4):342-51. PubMed ID: 21787121
[TBL] [Abstract][Full Text] [Related]
37. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte nuclear factor 1A deficiency causes hemolytic anemia in mice by altering erythrocyte sphingolipid homeostasis.
von Wnuck Lipinski K; Weske S; Keul P; Peters S; Baba HA; Heusch G; Gräler MH; Levkau B
Blood; 2017 Dec; 130(25):2786-2798. PubMed ID: 29109103
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells.
Kao LP; Morad SAF; Davis TS; MacDougall MR; Kassai M; Abdelmageed N; Fox TE; Kester M; Loughran TP; Abad JL; Fabrias G; Tan SF; Feith DJ; Claxton DF; Spiegel S; Fisher-Wellman KH; Cabot MC
J Lipid Res; 2019 Sep; 60(9):1590-1602. PubMed ID: 31363040
[TBL] [Abstract][Full Text] [Related]
40. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
